PubRank

Anna R Giuliano

Author PubWeight™ 199.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005 9.67
2 A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015 7.99
3 HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011 4.69
4 Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006 4.67
5 Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008 4.31
6 Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet 2013 3.25
7 Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine 2006 2.78
8 Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011 2.43
9 Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis 2011 2.19
10 Male circumcision and genital human papillomavirus: a systematic review and meta-analysis. Sex Transm Dis 2012 2.16
11 Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010 2.10
12 The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2010 1.94
13 Incidence trends in primary malignant penile cancer. Urol Oncol 2007 1.90
14 Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004 1.87
15 Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 2007 1.87
16 Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis 2011 1.84
17 Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis 2010 1.83
18 Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J Infect Dis 2009 1.80
19 The impact of a promotora on increasing routine chronic disease prevention among women aged 40 and older at the U.S.-Mexico border. Health Educ Behav 2004 1.78
20 Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis 2009 1.74
21 Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003 1.74
22 Updating the natural history of human papillomavirus and anogenital cancers. Vaccine 2012 1.65
23 Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis 2011 1.64
24 Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007 1.59
25 Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis 2008 1.55
26 Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. Vaccine 2007 1.53
27 Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. J Infect Dis 2013 1.43
28 Associations of Anogenital Low-Risk Human Papillomavirus Infection With Cancer and Acquisition of HIV. Sex Transm Dis 2015 1.40
29 Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011 1.40
30 Reliability of sample collection and laboratory testing for HPV detection in men. J Virol Methods 2008 1.38
31 Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am J Clin Nutr 2008 1.38
32 Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol Biomarkers Prev 2011 1.37
33 Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011 1.35
34 External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis 2011 1.34
35 Test-retest reliability of a sexual behavior interview for men residing in Brazil, Mexico, and the United States: the HPV in Men (HIM) Study. Am J Epidemiol 2009 1.33
36 Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 2004 1.32
37 Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev 2009 1.31
38 TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol 2009 1.26
39 The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study. Sex Transm Dis 2011 1.24
40 Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 2006 1.23
41 Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr 2003 1.21
42 Genital HPV infection and related lesions in men. Prev Med 2011 1.19
43 A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine. Vaccine 2004 1.17
44 Prevention of invasive cervical cancer in the United States: past, present, and future. Cancer Epidemiol Biomarkers Prev 2012 1.17
45 Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer 2008 1.17
46 IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States. Cancer Epidemiol Biomarkers Prev 2007 1.16
47 Provider counseling, health education, and community health workers: the Arizona WISEWOMAN project. J Womens Health (Larchmt) 2004 1.16
48 Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study. Genes Chromosomes Cancer 2013 1.16
49 Comparative analysis of breast cancer risk factors among Hispanic and non-Hispanic white women. Cancer 2010 1.16
50 Physical activity and breast cancer risk among women in the southwestern United States. Ann Epidemiol 2007 1.12
51 Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the Southeastern United States. Vaccine 2011 1.10
52 Fruit and vegetable consumption of older Mexican-American women is associated with their acculturation level. Ethn Dis 2006 1.08
53 Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor. Oncol Rep 2013 1.06
54 Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis 2011 1.05
55 Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control 2007 1.05
56 Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men. Cancer Res 2011 1.05
57 Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 2012 1.04
58 Consistent condom use is associated with lower prevalence of human papillomavirus infection in men. J Infect Dis 2010 1.04
59 Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men. Cancer Epidemiol Biomarkers Prev 2010 1.03
60 HPV 6/11, 16, 18 seroprevalence in men in two US cities. Sex Transm Dis 2009 1.02
61 Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2011 1.02
62 Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women. Cancer Causes Control 2008 1.01
63 Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors. Breast Cancer Res Treat 2011 1.01
64 Clustering of human papillomavirus (HPV) types in the male genital tract: the HPV in men (HIM) study. J Infect Dis 2011 1.01
65 Active and passive smoking, IL6, ESR1, and breast cancer risk. Breast Cancer Res Treat 2007 1.00
66 Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old. Clin Vaccine Immunol 2011 0.99
67 Broad HPV distribution in the genital region of men from the HPV infection in men (HIM) study. Virology 2013 0.99
68 Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer 2007 0.98
69 Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States. Breast Cancer Res Treat 2011 0.98
70 Risk factors for incident condyloma in a multinational cohort of men: the HIM study. J Infect Dis 2012 0.98
71 Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol 2007 0.98
72 Correlates of human papillomavirus viral load with infection site in asymptomatic men. Cancer Epidemiol Biomarkers Prev 2008 0.97
73 Genetic admixture among Hispanics and candidate gene polymorphisms: potential for confounding in a breast cancer study? Cancer Epidemiol Biomarkers Prev 2007 0.97
74 Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine 2013 0.96
75 Healthcare access and utilization among women 40 and older at the U.S.-Mexico border: predictors of a routine check-up. J Community Health 2003 0.96
76 Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women. Carcinogenesis 2013 0.95
77 Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men. Cancer Epidemiol Biomarkers Prev 2012 0.95
78 Ethnicity and nutrient intake among Arizona WISEWOMAN participants. J Womens Health (Larchmt) 2007 0.95
79 Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet. Eur J Nutr 2004 0.95
80 Racial and ethnic disparities in the incidence of invasive cervical cancer in Florida. Cancer 2009 0.94
81 Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United States. J Infect Dis 2012 0.94
82 Alternative dosage schedules with HPV virus-like particle vaccines. Expert Rev Vaccines 2014 0.93
83 Case-control study of smoking and non-melanoma skin cancer. Cancer Causes Control 2011 0.93
84 Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 2002 0.93
85 Ethnic and racial differences in HPV knowledge and vaccine intentions among men receiving HPV test results. Vaccine 2011 0.93
86 Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls. Cancer 2012 0.93
87 Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat 2013 0.93
88 Pap smear screening among women >/=40 years residing at the United States-Mexico border. Health Care Women Int 2007 0.92
89 Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat 2011 0.92
90 Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study. Int J Cancer 2013 0.92
91 Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer 2008 0.92
92 Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas. Cancer Epidemiol Biomarkers Prev 2009 0.92
93 Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer 2013 0.91
94 Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Causes Control 2007 0.91
95 Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States. Int J Cancer 2012 0.90
96 Adolescent sexual activity and cancer risk: physicians' duty to inform? Curr Med Res Opin 2014 0.90
97 Concordance of human papillomavirus types detected on the surface and in the tissue of genital lesions in men. J Med Virol 2013 0.90
98 Evolutionary ecology of human papillomavirus: trade-offs, coexistence, and origins of high-risk and low-risk types. J Infect Dis 2011 0.89
99 Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study. J Clin Virol 2013 0.88
100 Smoking and human papillomavirus (HPV) infection in the HPV in Men (HIM) study. Cancer Epidemiol Biomarkers Prev 2011 0.88
101 Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women. Cancer Epidemiol Biomarkers Prev 2008 0.88
102 Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults. Hum Vaccin 2011 0.88
103 Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males. Drugs 2011 0.87
104 Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 2005 0.87
105 Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin. J Invest Dermatol 2013 0.87
106 Genital human papillomavirus (HPV) concordance in heterosexual couples. J Infect Dis 2012 0.87
107 Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico. BMC Infect Dis 2010 0.87
108 The role of monogamy and duration of heterosexual relationships in human papillomavirus transmission. J Infect Dis 2013 0.86
109 Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida. J Infect Dis 2010 0.86
110 The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study. Cancer Causes Control 2013 0.86
111 Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sex Transm Dis 2010 0.86
112 HPV vaccination to prevent HIV infection: time for randomized controlled trials. Sex Transm Dis 2011 0.85
113 Associations between serum carotenoids and tocopherols and type-specific HPV persistence: the Ludwig-McGill cohort study. Int J Cancer 2007 0.85
114 Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study. BMC Infect Dis 2013 0.85
115 New virus associated with merkel cell carcinoma development. J Natl Compr Canc Netw 2010 0.85
116 Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States). Cancer Causes Control 2003 0.84
117 Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation? Matern Child Health J 2013 0.84
118 Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study. Sex Transm Dis 2013 0.84
119 No evidence of association between breast cancer risk and dietary carotenoids, retinols, vitamin C and tocopherols in Southwestern Hispanic and non-Hispanic White women. Breast Cancer Res Treat 2008 0.84
120 Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2002 0.84
121 SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study. PLoS One 2013 0.84
122 HPV-related information sharing and factors associated with U.S. men's disclosure of an HPV test result to their female sexual partners. Sex Transm Infect 2012 0.84
123 Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. J Infect Dis 2012 0.84
124 Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk. Obesity (Silver Spring) 2008 0.84
125 DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia. PLoS One 2012 0.83
126 Dietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women. PLoS One 2013 0.83
127 Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study. BMC Cancer 2012 0.83
128 High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study. BMC Infect Dis 2014 0.82
129 Quantification of secretory leukocyte protease inhibitor (SLPI) in oral gargle specimens collected using mouthwash. J Immunol Methods 2013 0.82
130 Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Res Treat 2009 0.82
131 Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types. J Mol Diagn 2004 0.82
132 Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecol Oncol 2010 0.82
133 Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study. Cancer Epidemiol Biomarkers Prev 2013 0.81
134 Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from Brazilian women. Cancer Epidemiol Biomarkers Prev 2004 0.81
135 Long-term weight gain among Hispanic and non-Hispanic White women with and without breast cancer. Nutr Cancer 2013 0.81
136 Epidermal growth factor receptor (EGFR) polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study. Int J Mol Epidemiol Genet 2013 0.81
137 HPV in female partners increases risk of incident HPV infection acquisition in heterosexual men in rural central Mexico. Cancer Epidemiol Biomarkers Prev 2012 0.80
138 Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009. Clin Ther 2010 0.80
139 Sexual behaviors and other risk factors for oral human papillomavirus infections in young women. Sex Transm Dis 2014 0.80
140 Human papillomavirus type distribution among heterosexual couples. J Low Genit Tract Dis 2012 0.80
141 Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study. Int J Cancer 2012 0.80
142 Circulating endogenous retinoic acid concentrations among participants enrolled in a randomized placebo-controlled clinical trial of retinyl palmitate. Cancer Epidemiol Biomarkers Prev 2004 0.79
143 Diet and biomarkers of oxidative damage in women previously treated for breast cancer. Nutr Cancer 2005 0.79
144 Human papillomavirus vaccination: component of an integrated HIV prevention program? AIDS 2012 0.78
145 TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer. Carcinogenesis 2013 0.78
146 ADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity. Cancer Causes Control 2012 0.78
147 Test-retest reliability and predictors of unreliable reporting for a sexual behavior questionnaire for U.S. men. Arch Sex Behav 2009 0.78
148 A prospective analysis of smoking and human papillomavirus infection among men in the HPV in Men Study. Int J Cancer 2013 0.78
149 Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response? Int J Cancer 2011 0.78
150 Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women. Breast Cancer Res Treat 2013 0.78
151 Differences between Hispanic and non-Hispanic white women with breast cancer for clinical characteristics and their correlates. Ann Epidemiol 2013 0.77
152 Cognitive and emotional responses to human papillomavirus test results in men. Am J Health Behav 2012 0.77
153 Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine. Hum Vaccin Immunother 2015 0.77
154 HPV-beyond cervical cancer (online resource center). Am J Med 2012 0.77
155 No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women. Cancer Prev Res (Phila) 2010 0.77
156 Men who purchase sex, who are they? An interurban comparison. J Urban Health 2013 0.77
157 Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial. Cancer Epidemiol Biomarkers Prev 2002 0.77
158 Folate, vitamin B12, and homocysteine status. findings of no relation between human papillomavirus persistence and cervical dysplasia. Nutrition 2003 0.76
159 Human papillomavirus vaccine administration among Medicaid providers who consistently recommended vaccination. Sex Transm Dis 2014 0.76
160 MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study. Nutr Cancer 2015 0.76
161 Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.com. Drugs R D 2012 0.75
162 Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2012 0.75
163 Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study. Cancer Causes Control 2014 0.75
164 Performance of the quantitative food frequency questionnaire used in the Brazilian center of the prospective study Natural History of Human Papillomavirus Infection in Men: The HIM Study. J Am Diet Assoc 2011 0.75
165 Combined antioxidant carotenoids and the risk of persistent human papillomavirus infection. Nutr Cancer 2010 0.75
166 Disparities in Penile Cancer. Cancer Control 2016 0.75
167 Dietary change in an intervention trial of wheat bran fiber and colorectal adenoma recurrence. Ann Epidemiol 2004 0.75
168 Estimating the burden of genital warts in Taiwan. Sex Health 2017 0.75
169 Personalizing Gastric Cancer Screening With Predictive Modeling of Disease Progression Biomarkers. Appl Immunohistochem Mol Morphol 2017 0.75
170 Human Immunodeficiency Virus Status Differentially Associated With Genital and Anal Human Papillomavirus Infection Among Chinese Men Who Have Sex With Men: A Cross-Sectional Survey. Sex Transm Dis 2017 0.75
171 Assessing dentists' human papillomavirus-related health literacy for oropharyngeal cancer prevention. J Am Dent Assoc 2017 0.75
172 Baseline dietary fiber intake and colorectal adenoma recurrence in the wheat bran fiber randomized trial. J Natl Cancer Inst 2002 0.75
173 Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections. Cancer Epidemiol 2012 0.75
174 SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021. Emerg Infect Dis 2022 0.75
175 Factors that affect the quality of cytologic cervical cancer screening along the Mexico-United States border. Am J Obstet Gynecol 2003 0.75